[1]
Shumway, MD, J.W., Ran, MD, R., McClusky, BS, Pharm, J., Rafique, MD, Z., Dark, MD, MPH, C., Peacock, MD, W.F., Cintron, MD, A. and Ludwig, MD, MPH, PhD, M. 2018. Impact of rescheduling hydrocodone-combination products in an urban Texas county healthcare system. Journal of Opioid Management. 14, 4 (Jul. 2018), 257–264. DOI:https://doi.org/10.5055/jom.2018.0457.